BCL2 and acute lymphoblastic leukemia: Moreover, the synergistic effect of CX-4945 in combination with Venetoclax in T-ALL cells is partially mediated by the reduction of BCL-2 and MCL-1 protein levels, which in turn promotes apoptosis in T-ALL cells.